Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 3 , Pages 230-235, September 2007

Total hCG Versus Free β-hCG Combined with Alpha-fetoprotein for Down Syndrome Screening in Taiwan

  • Tsang-Tang Hsieh

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taipei, Taiwan
  • ,
  • Jenn-Jeih Hsu

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Jenn-Jeih Hsu, Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University, 199, Tung-Hwa North Road, Taipei, Taiwan
  • ,
  • Po-Jen Cheng

      Affiliations

    • Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou, Taiwan
  • ,
  • Chien-Nan Lee

      Affiliations

    • Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Hei-Jen Jou

      Affiliations

    • Department of Obstetrics and Gynecology, Taiwan Adventist Hospital, Taipei, Taiwan
  • ,
  • Chih-Ping Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan

Accepted 26 September 2006.

Article Outline

Summary 

Objective

The purpose of this study was to compare the effectiveness between total human chorionic gonadotropin (hCG) and free β-hCG in two-marker Down syndrome screening programs during the second trimester in a Taiwanese population.

Materials and Methods

From a multicenter collaborative study, we investigated the second-trimester maternal serum levels of total hCG from 67 data, free β-hCG from 72 and alpha-fetoprotein (AFP) from 96 obtained from Taiwanese pregnant women carrying fetuses with Down syndrome.

Results

High total hCG and free β-hCG, as well as low AFP levels, were found with median values of 2.06, 2.49 and 0.77 multiples of the median (MoM), respectively. At a 5% false-positive rate, total hCG and free β-hCG could detect 31% and 43% of Down syndrome pregnancies, respectively, whilst AFP alone could detect only 15% of affected cases. When combined with maternal age-specific risk, total hCG could achieve a 52% detection rate, free β-hCG a 54% and AFP a 39%. Combined total hCG and AFP achieved a detection rate of 55%, and combined free β-hCG and AFP achieved a rate of 60%.

Conclusion

The measurement of free β-hCG is more beneficial than total hCG in serum screening for Down syndrome during the second trimester of pregnancy.

Key Words:  AFP , Asians , Down syndrome screening , free β-hCG , total hCG

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Hsu JJ , Hsieh TT , Hsieh FJ . Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group . Obstet Gynecol . 1996;87:943–947
  2. Palomaki GE , Knight GJ , McCarthy JE , Haddow JE , Donhowe JM . Maternal serum screening for Down syndrome in the United States: a 1995 survey . Am J Obstet Gynecol . 1996;176:1046–1051
  3. Macintosh M , Ellis A , Cuckle H , Seth J . Variation in biochemical screening for Down's syndrome in the United Kingdom . Br J Obstet Gynaecol . 1998;105:465–467
  4. Macri JN , Kasturi RV , Krantz DA , et al.   Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin . Am J Obstet Gynecol . 1990;163:1248–1253
  5. Spencer K . Evaluation of an assay of the free β-subunit of choriogonadotropin and its potential value in screening for Down's syndrome . Clin Chem . 1991;37:809–814
  6. Spencer K , Coombes EJ , Mallard AS , Ward AM . Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers . Ann Clin Biochem . 1992;29:506–518
  7. Wald N , Densem J , Stone R , Cheng R . The use of free β-hCG in antenatal screening for Down's syndrome . Br J Obstet Gynaecol . 1993;100:550–557
  8. Hsu JJ , Hsieh TT , Soong YK , Spencer K . Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age . Prenat Diagn . 1997;17:707–716
  9. Wald NJ , Densem JW , Smith D , Klee GG . Four-marker serum screening for Down's syndrome . Prenat Diagn . 1994;14:707–716
  10. Knight GJ , Palomaki GE , Neveux LM , Fodor KK , Haddow JE . hCG and the free β-subunit as screening tests for Down syndrome . Prenat Diagn . 1998;18:235–245
  11. Wenstrom KD , Owen J , Chu DC , Boots L . Free β-hCG sub-unit versus intact hCG in Down syndrome screening . Obstet Gynecol . 1997;90:370–374
  12. Spencer K . Is the measurement of unconjugated oestriol of value in screening for Down's syndrome . In:  Grudzinskas JG ,  Chard T ,  Chapman M ,  Cuckle H editor. Screening for Down's Syndrome . Cambridge: Cambridge University Press; 1994;p. 141–161
  13. Hsu JJ , Chiu TH , Chen KC , Liou JD , Hsieh TT , Soong YK . Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation . Chang Gung Med J . 1994;17:309–315
  14. Hsu JJ , Hsieh TT , Lo LM , Soong YK . Midtrimester human chorionic gonadotropin levels: Normal references values in Chinese pregnant women . Chang Gung Med J . 1995;18:240–247
  15. Hsu JJ , Hsieh TT , Hung TH , Chiang CH . Midtrimester maternal serum free beta-human chorionic gonadotropin levels: normal reference values for Taiwanese women . Chang Gung Med J . 1998;21:277–282
  16. Hsu JJ , Hsieh TT , Soong YK . Influence of maternal age and weight on second-trimester serum alpha-fetoprotein, total and free beta human chorionic gonadotropin levels . Chang Gung Med J . 1997;20:181–186
  17. Cuckle HS , Wald NJ , Thompson SG . Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level . Br J Obstet Gynaecol . 1987;94:387–402
  18. Reynolds TM , Penney MD . The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy . Ann Clin Biochem . 1990;27:452–458
  19. Bogart MH , Pandian MR , Jones OW . Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities . Prenat Diagn . 1987;7:623–630
  20. Canick JA , Knight GJ . Multiple-marker screening for fetal Down syndrome . Contemp Ob Gyn . 1992;4:3–12
  21. Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, et al. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong . Prenat Diagn . 1998;18:585–589
  22. Eldar-Geva T , Hochberg A , deGroot N , Weinstein D . High maternal serum chorionic gonadotropin level in Down's syndrome pregnancies is caused by elevation of both sub-units messenger ribonucleic acid level in trophoblasts . J Clin Endocrinol Metab . 1995;80:3528–3531
  23. Ryall RG , Staples AJ , Robertson EF , Pollard AC . Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses . Prenat Diagn . 1992;12:251–261
  24. Macri JN , Spencer K , Garver K , et al.   Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome . Prenat Diagn . 1994;14:97–103
  25. Cuckle HS , Wald NJ , Lindenbaum RH . Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome . Lancet . 1984;1:926–929
  26. Spencer K , Carpenter P . Screening for Down's syndrome using serum α-fetoprotein: a retrospective study indicating caution . Br Med J (Clin Res Ed) . 1985;290:1940–1943
  27. Cuckle HS , Ellis AR , Seth J . Provision of screening for Down's syndrome . BMJ . 1995;311:512–514
  28. Spencer K , Macri JN , Aitken DA , Connor JM . Free β-hCG as first-trimester marker for fetal trisomy . Lancet . 1992;339:1480–1481
  29. Wald NJ , Kennard A , Hackshaw AK . First trimester serum screening for Down's syndrome . Prenat Diagn . 1995;15:1227–1240

PII: S1028-4559(08)60025-X

doi:10.1016/S1028-4559(08)60025-X

Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 3 , Pages 230-235, September 2007